KNOW YOUR GENE, GET BETTER LIFE
USE STRENGTH INTELLIGENCE
A CURIOUS GENE
McLean, Virginia - (Business Wire / News Wire) September 29, 2017 - Are you curious from birth? This fall, Curio Collection by Hilton ™, one of the market-leading brands of the Hilton (New York Stock Exchange: HLT), paves the way for exploratory travelers to help them discover something Giving.
The Curio Collection by Hilton found that consumers surveyed pursued special experiences as a vital part of their travels. As demonstrated by this insight and brand name, through curiosity, the Curio Collection has attempted a scientific approach to sponsoring DNA testing for over 30 enthusiastic travelers who enjoy sharing their trips with social media followers . The purpose of these travelers is to determine if they have the DRD4-7R gene, better known as the "wanderlust gene," which was part of an effort to understand the innate desire to travel. Today, this collection brand introduces a social media quiz, "Are you curious?" So that anyone can try their curiosity.
"Curious travelers have a desire to discover something special and are looking for a hotel that is a very important part of their travel experience," said Stuart Foster, vice president of Global Brand Marketing at the Curio Collection by Hilton. . "We use the Curious Gene program to help decide the true moment of our next trip in one of our more than 40 global hotels and resorts in select, carefully selected, I would like to encourage all of them to be curious, "said Lil 'B Coffee & Eatery at The Darcy Washington DC in Sylen. A gourmet adventure or a calm seaside spa experience in California's traditional Hotel del Coronado can be one of those experiences. "
Science and curiosity type
Scientists believe that 7R transgenes derived from the gene DRD4 appear in about one in five people, about 20% of the total population. In curiosity genetic research, the Curio Collection by Hilton collaborates with Fulgent Genetics, a genetic research institute, and research partner BrandIQ, to target 30 travel influencers that affect travel I did a test to determine who had a 'curious gene'. Each influenza also participated in qualitative research, which included detailed online postings and surveys. The researchers applied the results of the research and developed an algorithm that classifies curiosity into the following five types by using existing scientific information related to the 7R gene.
http://www.newswire.co.kr/newsRead.php?no=857343
CANCER GENE ANALYSIS TECHNOLOGY
The 13th International Cancer Genome Consortium (ICGC) symposium opened at the Millennium Seoul Hilton Hotel on December 12. The global consortium is one of the largest research programs in the biotechnology / medicine field since the Human Genome Project and has been leading various projects on cancer genome mapping since 2008.
The symposium was attended by more than 300 researchers from over 70 countries around the world, sharing the latest insights on the study of the whole oil field. Chung Jong-sun, CEO of Shintechba Bio, a domestic genome-wide data analysis company, announced the "Cancer Allele Screening Hault Typing Technology Using Integrated Data of ICGC and 1000 Genome Project".
Chung, a member of the ICGC, also presented a study in September last year in Boston using a supercomputer-based genome-wide data to identify the cause of cancer. It was the result of analysis of more than 500 genes known to be related to mutation and cancer of 60 genes including 'BRCA1' known as the cause of cancer.
Professor Yoon Sung-soo and Professor Ko Young-il of the Department of Hematology and Oncology at Seoul National University Hospital presented the topics of 'multiple myeloma project' and 'future blood cancer genome profiling'. Professor Yoon participated in international joint research on malignant tumor genome guidance since last year including the blood cancer project in 2013.
This year, 14 years have passed since the completion of the Human Genome Project, a multi-national study to analyze the entire human genome for the first time. In the meantime, many countries, including the United States, have gathered a lot of information through various genetic studies and have been fiercely fighting to unlock the secrets.
The cost of decoding and analyzing the genome of the battlefield genome, which could last several years before reaching a trillion won, has become possible within a few days of 1 million won. Illumina, a leader in genome analysis this year, We introduced a new analytical instrument that will Due to the development and diversification of these genome-based technologies, we anticipate the rapid growth and development of the individual genome market as a new convergence technology field that will lead the fourth industrial revolution in the future.
Recently, gene analysis has started to be applied to diverse fields such as diagnostic treatments beyond the level of research, and furthermore, it has begun to be applied to various lifestyles of our lives as well as personal health and exercise management. This change has led to an era in which genetic analysis can be applied to various fields of life beyond the merits of research and medical information. I'm talking.
In recent years, the US, China, and other countries have been concentrating on securing individual genetic information. In 2015, the US government announced a precision medical project and analyzed more than 1 million genetic information in the next five years. And the UK also announced a 100,000 gene project. In China, BGI and Novogene have secured more than a few trillion won in funding and have been playing a major role in preoccupying the gene market through low-cost gene decoding by providing the world's largest gene decoding system.
In the case of the Illuminator in the United States, the next few years have predicted an era in which genetic analysis of all newborns is performed and have made various efforts and preparations for a new era. As part of that effort, we announced a $ 1000 global genome analysis in 2014 and launched the Global Screening Array (GSA), one of the largest genetic projects in 2016, to screen and analyze 10 million genes within a few years. The 12 most influential research areas were selected and presented as a consortium. Through this consortium, the project aims to get the largest unified gene data in the shortest time and to prepare various genome era by developing various research and application applications.
We are now making more efforts to apply to various application fields and new drug development and treatment by big data analysis including machine running and artificial intelligence by securing more genetic information from all over the world. Has become a core competency. A variety of DNA apps using these gene data have started to emerge, and the US MIT Technology Review has selected the DNA App Store to analyze individual genes with the top ten innovations in 2016. Helix in the US and MyGenomeBox in Korea have started to develop technologies and open up the market, especially MyGenomeBox, as the world's first realization of a platform to share a personal genome.
Now that the countries or companies that have more information or diverse databases have secured the greatest future competitiveness, and when they have the ability to take control and utilize the information, the information capitalism era has opened up to lead the world You can. The personal genome analysis project is the core of big data information business. By 2025, genetic information is expected to accumulate much more than Twitter or YouTube data. Thus, companies and countries that have acquired genetic information are preparing for treatment and drug development based on genes using artificial intelligence or supercomputers. Advanced genomics companies in the US and China are investing heavily and expanding their business for machine learning of genetic information.
BGI, the world's largest geneticist, recently announced the resignation announcement and the establishment of an artificial intelligence startup based on genetic information. In the case of 23andMe in the United States, which is known to have secured the most personal genetic information so far, the company will establish a new drug development information company through Virtual Clinical of the customer's gene data and become the world's largest gene-based pharmaceutical company in connection with the Google biotechnology business. I came to an ambitious announcement. Now, companies and countries that have not acquired valuable information or databases in the era of the Fourth Industrial Revolution have become a reality that can not but be taken away from fierce world information competition.
In addition, a company that develops a variety of applications that can leverage this information will be the centerpiece of future information and the Big Data industry. Now, securing and utilizing valuable information will be an indicator of competitiveness of a country or a company. In particular, the field of personal genome will start to be used as core information of all convergence industries. Where there is a lot of genetic information, you will have the opportunity to expand your business and market with more information using that data.
Korea has now become a time to innovate to join the frontrunner in the global data market and the importance of genetic information. In the meantime, Korea has been an IT powerhouse envied by the world in a short time based on excellent human resources and excellent infrastructure. Now, based on this IT advantage, we need to get ready to leap to information power through acquisition and utilization of data. Old-age regulations or constraints will not only undermine the development of new businesses, but will also dilute the many achievements and progress we have made over the years. Since Korea already has a good infrastructure to become an information superpower, securing personal genetic information and developing related industries will be Korea's new growth engine that will have the greatest competitiveness.
In this historical point of view, recently, Korea's genetic testing and some deregulation measures in the utilization market are very important decisions in terms of providing not only institutionalized analysis and utilization of individual genes, but also breakthroughs in securing genetic big data. Personal genetic information will be an important opportunity to present a stepping stone to future advanced genetic information by utilizing big data beyond the level of understanding individual genes and anticipating and preventing potential diseases.
http://www.biospectator.com/view/news_view.php?varAtcId=3406